Research institute for biological safety problems
The World Health Organization (WHO) has officially included our domestic inactivated vaccine, developed by scientists of our Institute, into the list of vaccines approved for clinical trials. Kazakhstan vaccine with…
Preclinical studies of the Kazakhstan inactivated COVID-19 vaccine developed by the Research Institute for Biological Safety Problems (RIBSP) of SC MES RK on the basis of the pharmacological testing laboratory…
In early June this year, the Prime Minister of the Republic of Kazakhstan Askar Uzakpaevich Mamin visited the RSE ” Research Institute for Biological Safety Problems” of the Science Committee…
At the Scientific Research Institute for Biological Safety Problems of the Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan (hereinafter – RIBSP), on July…
On August 03, 2020 Akim of Zhambyl region Saparbayev B.M. accompanied by the Akim of the Kordai region and other representatives of the akimats of the Zhambyl oblast, the Kordai…
On July 31, 2020, the second Kazakhstan vaccine of the RSE “Research Institute for Biological Safety Problems” of the SC MES RK was successfully registered on the website of the…
On July 28, 2020, within the framework of international cooperation, an online video conference was held between the RSE RIBSP MES RK and the DUKE-NUS School of Medicine (Singapore). The…
The RSE “Research Institute for Biological Safety Problems” of the SC MES RK (RIBSP), as the main institute for virological and microbiological research, still uses the “gold standard” methods, using…
We congratulate the head of the laboratory “Monitoring of infectious diseases”, candidate of veterinary sciences, professor Orynbayev Mukhit Barmakuly on his unanimous election to the highest academic title – Corresponding…
By the decree of the President of the Republic of Kazakhstan K.K. Tokayev No. 353 of 06/19/2020 for fruitful work in the field of education, health care, social protection, as…